Detalhe da pesquisa
1.
Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation.
Mol Cell
; 82(18): 3438-3452.e8, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055235
2.
The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.
Clin Transl Med
; 13(4): e1217, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029785
3.
KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors.
Mol Oncol
; 16(17): 3066-3081, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313064
4.
mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer.
Mol Cancer Res
; 20(7): 1108-1121, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348729
5.
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma.
J Exp Clin Cancer Res
; 40(1): 256, 2021 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34399807
6.
Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond.
Trends Cancer
; 6(2): 130-146, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32061303
7.
Resistance to Antibody-Drug Conjugates.
Cancer Res
; 78(9): 2159-2165, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653942
8.
Refining Early Antitumoral Drug Development.
Trends Pharmacol Sci
; 39(11): 922-925, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30279003
9.
Overestimation of Albumin Measured by Bromocresol Green vs Bromocresol Purple Method: Influence of Acute-Phase Globulins.
Lab Med
; 49(4): 355-361, 2018 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29790973
10.
Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity.
Cancer Res
; 77(17): 4639-4651, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687619
11.
Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer.
Clin Cancer Res
; 23(22): 7006-7019, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28821558
12.
Multisite phosphorylation of P-Rex1 by protein kinase C.
Oncotarget
; 7(47): 77937-77949, 2016 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27788493
13.
RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression.
Cancer Cell
; 39(3): 294-296, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513349
14.
Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling.
Oncotarget
; 6(30): 30057-71, 2015 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26336133